Skip to main content
Top
Published in: Diabetologia 12/2004

01-12-2004 | Article

Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study

Authors: The DECODE Study Group, on behalf of the European Diabetes Epidemiology Group

Published in: Diabetologia | Issue 12/2004

Login to get access

Abstract

Aims/hypothesis

Risk scores have been developed to predict cardiovascular or coronary risk, and while most have included diabetes as a risk factor, none have included lower glucose concentrations, either at fasting or following a 2-h oral glucose tolerance test. This article develops 5- and 10-year risk scores for cardiovascular mortality that include glucose concentrations as well as known diabetes status.

Methods

Data is from the DECODE cohort: 16,506 men and 8,907 women from 14 European studies. The risk factors studied were as follows: age, fasting and 2-h glucose (including cases of known diabetes), fasting glucose alone (including cases of known diabetes), cholesterol, smoking status, systolic blood pressure and BMI. For an absolute risk score the 1995 country- and sex-specific cardiovascular death rates were used.

Results

In men, for both 5- and 10-year cardiovascular mortality, after adjusting for age and study centre, all studied risk factors, except BMI, were significantly associated with cardiovascular mortality (p<0.05). These results were unchanged in multivariate models with all factors included. In women, after adjusting for age and centre, glucose categories, systolic blood pressure and BMI were predictive of 5-year cardiovascular mortality. With all factors in the model, only age and glucose categories were predictive. In terms of 10-year cardiovascular mortality, smoking status and blood pressures were also predictive in the women. For men and women, the same scores were used for the risk factors, except for age and glucose categories where the hazard ratios differed significantly.

Conclusions/interpretation

Including glucose concentrations as well as diabetic status provides quantitative information on cardiovascular risk prediction.
Literature
1.
go back to reference De Backer G, Ambrosioni E, Borch-Johnsen K et al. (2003) European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehabil 10:S1–S10PubMed De Backer G, Ambrosioni E, Borch-Johnsen K et al. (2003) European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehabil 10:S1–S10PubMed
2.
go back to reference Grundy SM, Balady GJ, Criqui MH et al. (1988) Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation 97:1876–1887 Grundy SM, Balady GJ, Criqui MH et al. (1988) Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation 97:1876–1887
3.
go back to reference Jackson R (2000) Guidelines on preventing cardiovascular disease in clinical practice. BMJ 320:659–661CrossRefPubMed Jackson R (2000) Guidelines on preventing cardiovascular disease in clinical practice. BMJ 320:659–661CrossRefPubMed
4.
go back to reference Grundy SM, D’Agostino RB Sr, Mosca L et al. (2001) Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood Institute workshop. Circulation 104:491–496PubMed Grundy SM, D’Agostino RB Sr, Mosca L et al. (2001) Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood Institute workshop. Circulation 104:491–496PubMed
5.
go back to reference Kannel WB, Castelli WP, McNamara PM (1967) The coronary profile: 12-year follow-up in the Framingham Study. J Occup Med 9:611–619PubMed Kannel WB, Castelli WP, McNamara PM (1967) The coronary profile: 12-year follow-up in the Framingham Study. J Occup Med 9:611–619PubMed
6.
go back to reference Gordon T, Kannel WB (1982) Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application. Am Heart J 103:1031–1039CrossRefPubMed Gordon T, Kannel WB (1982) Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application. Am Heart J 103:1031–1039CrossRefPubMed
7.
go back to reference Anderson KM, Wilson PWF, Odell PM, Kannel WB (1991) An updated coronary risk profile. A statement for health professionals. Circulation 83:356–362PubMed Anderson KM, Wilson PWF, Odell PM, Kannel WB (1991) An updated coronary risk profile. A statement for health professionals. Circulation 83:356–362PubMed
8.
go back to reference Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–1847PubMed Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–1847PubMed
9.
go back to reference ERICA Research Group (1991) Prediction of coronary heart disease in Europe. The 2nd report of the WHO-ERICA Project. Eur Heart J 12:291–297PubMed ERICA Research Group (1991) Prediction of coronary heart disease in Europe. The 2nd report of the WHO-ERICA Project. Eur Heart J 12:291–297PubMed
10.
go back to reference Tunstall-Pedoe H (1991) The Dundee coronary risk-disk for management of change in risk factors. BMJ 303:744–747PubMed Tunstall-Pedoe H (1991) The Dundee coronary risk-disk for management of change in risk factors. BMJ 303:744–747PubMed
11.
go back to reference Knuiman, MW, Vu HTV (1997) Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores. J Epidemiol Community Health 51:515–519PubMed Knuiman, MW, Vu HTV (1997) Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores. J Epidemiol Community Health 51:515–519PubMed
12.
go back to reference Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel J-P on behalf of the INDANA project steering committee (2001) A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomized controlled trials. BMJ 323:75–81CrossRefPubMed Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel J-P on behalf of the INDANA project steering committee (2001) A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomized controlled trials. BMJ 323:75–81CrossRefPubMed
13.
go back to reference Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) Study. Circulation 105:310–315CrossRefPubMed Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) Study. Circulation 105:310–315CrossRefPubMed
14.
go back to reference Glynn RJ, L’Italien GJ, Sesso HD, Jackson EA, Buring JE (2002) Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension 39:105–110CrossRefPubMed Glynn RJ, L’Italien GJ, Sesso HD, Jackson EA, Buring JE (2002) Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension 39:105–110CrossRefPubMed
15.
go back to reference Thomsen TF, McGee D, Davidsen M, Jorgensen T (2002) A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol 31:817–822CrossRefPubMed Thomsen TF, McGee D, Davidsen M, Jorgensen T (2002) A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol 31:817–822CrossRefPubMed
16.
go back to reference Chambless LE, Folsom AR, Sharrett AR et al. (2003) Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol 56:880–889CrossRefPubMed Chambless LE, Folsom AR, Sharrett AR et al. (2003) Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol 56:880–889CrossRefPubMed
17.
go back to reference Conroy RM, Pyörälä K, Fitzgerald AP et al. and the SCORE project group (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987–1003CrossRefPubMed Conroy RM, Pyörälä K, Fitzgerald AP et al. and the SCORE project group (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987–1003CrossRefPubMed
18.
go back to reference Haq IU, Ramsay LE, Yeo WW, Jackson PR, Wallis EJ (1998) Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart 81:40–46 Haq IU, Ramsay LE, Yeo WW, Jackson PR, Wallis EJ (1998) Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart 81:40–46
19.
go back to reference D’Agostino RB Sr, Grundy S, Sullivan LM, Wilson P for the CHD Risk Prevention Group (2001) Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286:180–187PubMed D’Agostino RB Sr, Grundy S, Sullivan LM, Wilson P for the CHD Risk Prevention Group (2001) Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286:180–187PubMed
20.
go back to reference Game FL, Jones AF (2001) Coronary heart disease risk assessment in diabetes mellitus—a comparison of PROCAM and Framingham risk assessment functions. Diabet Med 18:355–359CrossRefPubMed Game FL, Jones AF (2001) Coronary heart disease risk assessment in diabetes mellitus—a comparison of PROCAM and Framingham risk assessment functions. Diabet Med 18:355–359CrossRefPubMed
21.
go back to reference Bastuji-Garin S, Deverly A, Moyse D et al. on behalf of the INSIGHT committees and investigators (2002) The Framingham prediction rule is not valid in a European population of treated hypertensive patients. J Hypertens 20:1973–1980CrossRefPubMed Bastuji-Garin S, Deverly A, Moyse D et al. on behalf of the INSIGHT committees and investigators (2002) The Framingham prediction rule is not valid in a European population of treated hypertensive patients. J Hypertens 20:1973–1980CrossRefPubMed
22.
go back to reference Cappuccio FP, Oakeshott P, Strazzullo P, Kerry SM (2002) Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study. BMJ 325:1271–1274CrossRefPubMed Cappuccio FP, Oakeshott P, Strazzullo P, Kerry SM (2002) Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study. BMJ 325:1271–1274CrossRefPubMed
23.
go back to reference Hense HW, Schulte H, Lôwel H, Assmann G, Keil U (2003) Framingham risk function overestimates risk of coronary heart disease in men and women from Germany–results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 24:937–945CrossRefPubMed Hense HW, Schulte H, Lôwel H, Assmann G, Keil U (2003) Framingham risk function overestimates risk of coronary heart disease in men and women from Germany–results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 24:937–945CrossRefPubMed
24.
go back to reference Empana JP, Ducimetière P, Arveiler D et al. on behalf of the PRIME Study Group (2003) Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 24:1903–1911CrossRefPubMed Empana JP, Ducimetière P, Arveiler D et al. on behalf of the PRIME Study Group (2003) Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 24:1903–1911CrossRefPubMed
25.
go back to reference The DECODE Study Group on behalf of the European Diabetes Epidemiology Group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354:617–621CrossRefPubMed The DECODE Study Group on behalf of the European Diabetes Epidemiology Group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354:617–621CrossRefPubMed
26.
go back to reference The DECODE Study Group on behalf of the European Diabetes Epidemiology Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397–405CrossRefPubMed The DECODE Study Group on behalf of the European Diabetes Epidemiology Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397–405CrossRefPubMed
27.
go back to reference Balkau B, Shipley M, Jarrett RJ et al. (1998) High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21:360–367PubMed Balkau B, Shipley M, Jarrett RJ et al. (1998) High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21:360–367PubMed
28.
go back to reference Balkau B, Bertrais S, Ducimetière P, Eschwège E (1999) Is there a glycaemic threshold for mortality risk? Diabetes Care 22:696–699PubMed Balkau B, Bertrais S, Ducimetière P, Eschwège E (1999) Is there a glycaemic threshold for mortality risk? Diabetes Care 22:696–699PubMed
29.
go back to reference Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233–240PubMed Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233–240PubMed
30.
go back to reference de Vegt F, Dekker JM, Ruhe HG et al. (1999) Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42:926–931CrossRefPubMed de Vegt F, Dekker JM, Ruhe HG et al. (1999) Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42:926–931CrossRefPubMed
31.
go back to reference The DECODE Study Group (2003) Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 26:688–696PubMed The DECODE Study Group (2003) Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 26:688–696PubMed
32.
go back to reference World Health Organization (1977) International classification of diseases, injuries and causes of death, revision 9. WHO, Geneva World Health Organization (1977) International classification of diseases, injuries and causes of death, revision 9. WHO, Geneva
33.
go back to reference World Health Organization (1993) International classification of diseases, injuries and causes of death, revision 10. WHO, Geneva World Health Organization (1993) International classification of diseases, injuries and causes of death, revision 10. WHO, Geneva
34.
go back to reference DECODE Study Group (2003) Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 46:608–617PubMed DECODE Study Group (2003) Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 46:608–617PubMed
35.
go back to reference World Health Organization Consultation (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Report of a WHO Consultation, WHO, Geneva World Health Organization Consultation (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Report of a WHO Consultation, WHO, Geneva
36.
go back to reference World Health Organization Mortality Data Base. Available from http://www.who.int/whosis World Health Organization Mortality Data Base. Available from http://​www.​who.​int/​whosis
37.
go back to reference Stevens RJ, Kothari V, Adler AI, Stratton IM, United Kingdom Prospective Diabetes Study (UKPDS) Group (2001) The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 101:671–679CrossRef Stevens RJ, Kothari V, Adler AI, Stratton IM, United Kingdom Prospective Diabetes Study (UKPDS) Group (2001) The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 101:671–679CrossRef
38.
go back to reference Kothari V, Stevens RJ, Adler AI et al. (2002) UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 33:1776–1781CrossRefPubMed Kothari V, Stevens RJ, Adler AI et al. (2002) UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 33:1776–1781CrossRefPubMed
39.
go back to reference Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557–1565CrossRefPubMed Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557–1565CrossRefPubMed
40.
go back to reference Lind P, Hedblad B, Stavenow L, Janzon L, Eriksson KF, Lindgarde F (2001) Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: a long-term cohort study. Arterioscler Thromb Vasc Biol 21:452–458PubMed Lind P, Hedblad B, Stavenow L, Janzon L, Eriksson KF, Lindgarde F (2001) Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: a long-term cohort study. Arterioscler Thromb Vasc Biol 21:452–458PubMed
41.
go back to reference Gerstein HC, Mann JF, Yi Q et al. for the HOPE Study Investigators (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421–426CrossRefPubMed Gerstein HC, Mann JF, Yi Q et al. for the HOPE Study Investigators (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421–426CrossRefPubMed
42.
go back to reference Hall LM, Jung RT, Leese GP (2003) Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ 326:251–252CrossRefPubMed Hall LM, Jung RT, Leese GP (2003) Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ 326:251–252CrossRefPubMed
Metadata
Title
Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study
Authors
The DECODE Study Group
on behalf of the European Diabetes Epidemiology Group
Publication date
01-12-2004
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1574-5

Other articles of this Issue 12/2004

Diabetologia 12/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.